KSHB: ‘Have Hope’: Study Shows Immunotherapy Continues To Change Future of Cancer Treatment
A new phase in a clinical trial for treating certain kinds of tumors with immunotherapy continues to pave the way for the future of treating patients with cancer.
Immunotherapy is making a big impact in the lives of patients like Michael Delaney, who battles a rare cancer known as thymic carcinoma and has received almost 200 rounds of immunotherapy.
KSHB talked with Dr. Marc Roth, Medical Director of Gastrointestinal Oncology at Saint Luke's, and Dr. Timothy Pluard, Medical Director at Saint Luke's Cancer Institute, about the latest research on immunotherapy and how it works.
Relevant News
Patient Stories
How One Retreat Helped Kathy Find Peace During Her Cancer Journey
News
Health News You Can Use: Saint Luke’s Koontz Center for Advanced Breast Cancer’s 10th Anniversary
News
KSHB: Sporting KC Players Visit Patients Battling Cancer at Saint Luke’s Cancer Institute
News
Health News You Can Use: Breast Cancer Awareness Month: High Risk Breast Clinic
News
KSHB: Pope Leo XIV Diagnosed with Lung Cancer: What To Know
News